CAS 2095417-05-1

1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-methyl-β-D-ribo-hex-5-enofuranosyl]uracil

CAS : 2095417-05-1

Nucleoside Derivatives - Phosphorus-containing nucleotide; 2’-Modified nucleoside; 5’-Modified nucleoside

Formule : C₁₅H₂₃N₂O₈P

Couleur et forme : Solid

Masse moléculaire : 390.33

Ref: TM-TNU1008

1-[(5E)-5,6-Dideoxy-6-(diethoxy phosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil

CAS : 2095417-05-1

1-[(5E)-5,6-Dideoxy-6-(diethoxy phosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil is a novel monophosphate that was synthesized by modifying a known anticancer nucleoside. It is an activator of the antiviral ribonucleotide reductase and deoxyribonucleotide reductase. 1-[(5E)-5,6-Dideoxy-6-(diethoxy phosphinyl)-2-O-methyl-beta-D-ribohexanofuranosyl]uracil has been shown to inhibit the proliferation of cancer cells in vitro and in vivo. It also inhibits tumor growth without affecting normal tissue.

Degré de pureté : Min. 95%

Ref: 3D-PD162928